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List of abbreviations 





ACTH adrenocorticotrop releasing hormone 
ANOVA analysis of variance 
COMT catechol-o-methyltransferase 
CRH corticotrop releasing hormone 
DA dopamine 
DDT dichloro-diphenyl trichloro-ethane 
DMEM Dulbecco’s modified essential medium 
EDC endocrine disrupting chemicals 
EDTA ethylenediamine tetra-acetic acid (disodic salt) 
EPM elevated plus maze 
FCS foetal calf serum 
GGT gamma-glutamyl transpeptidaze 
HCB hexachlorobenzene 
IARC International Agency for Research on Cancer 
LC locus coeruleus 
LDCV large dense core vesicle 
L-DOPA L-dihydroxy-phenylalanine 
MAO A monoamine oxidase A 
MAO B monoamine oxidase B 
NA noradrenaline 
NA-erg noradrenerg 
OF open field 
OT oxytocin 
OT-erg oxytocinerg 
PAH policyclic aromatic hydrocarbons 
PCB polychlorinated biphenyls 
POP persistent organic pollutants 
PVN nucleus paraventricularis 
RIA radioimmunoassay 
SCN nucleus suprachiasmaticus 
SGOT serum glutamate oxalacetate transaminase 
SGPT serum glutamate piruvate transaminase 
SON nucleus supraopticus 
SSRI selective serotonin reuptake inhibitor 
TCB trichlorobenzene 
VP vasopressin 




By homeostasis, living organisms maintain equilibrium with their 
environments, adapt themselves to the changing external and internal 
circumstances. Any current state of equilibrium can be interpreted as the 
change of biocommunication processes emerging under the effect of 
environmental parameters. Living organisms of effective adaptation abilities 
first show neurogenic, then neuroendocrine, neuroendocrine-immune and 
the currently known highest level of psycho-neuroendocrine-immune 
communication accommodation. Chemicals are widely used in industry and 
agriculture. These include, among others, substances resistant to 
degradation owing to their stable chemical structure and thereby 
representing a particularly high environmental risk – such as dichloro-
diphenyl-trichloroethane (DDT), or hexachlorobenzene (HCB), for 
example, known as persistent organic pollutants (POP). The heterogeneous 
family of POPs are substances interfering with endocrine homeostasis and 
communication; these are identified as endocrine-disrupting chemicals 
(EDC). Studies on the impacts of EDC compounds on behaviour have shed 
light on information relating to sexual behaviour, emotional tone, 
motivation, communication, anxiety, aggression, dominance and forms of 
social behaviour. EDC compounds may activate or inhibit the endocrine 
system, thus the synthesis of hormones, their storage, release, transport and 
metabolism, as well as the receptor recognition and binding, and 
furthermore they may interfere in neuroendocrine processes affecting 
induced responses. In the central nervous system, the structures responsible 
for endocrine reactions and behavioural functions are common, and 
therefore hormones often exercise a direct impact on behaviour (and vice 
versa), or alternatively they may indirectly influence it via the modification 
of metabolism. 
Objectives 
(1) In the course of our work, from among EDC compounds and the group 
of aromatic halogenated hydrocarbons ClB has been chosen as a model 
compound to use this represented group of compounds for calling the 
attention to the threat that may be conveyed by the modification of 
homeostatic systems. By now, ClBs have been banned from agriculture, 
although are still in use in some developing countries. Their industrial use is 
restricted by exposure limits, imposed by law. ClB’s most stabile lipophylic 
representative is HCB. From this xenobiotic group, there are derivatives of 
lower chlorine substitution and lipophylic properties present in our 
environment, while their chemical reactivity is higher than that of HCB.  
(2) Living organisms are normally subject to several exposure harms, i.e. 
stress (effects) simultaneously, and therefore we have also set the objective 
to develop and standardize a research protocol that is suitable for the 
examination of effects triggered by combined chemical loadings. In our 
researches, we have tried to work out and standardize the examination 
model system for the combined effects of two chlorobenzene derivatives, 
HCB and TCB.  
(3) In our studies, we endeavoured to develop an in vivo treatment protocol 
for modelling chemical exposure, in order to acquire data suitable for 
evaluating the preservation of the environmental adaptive potential 
maintained through accommodation. 
(4) Our primary objective was to evaluate the effects of combined ClB 
exposure on the neuroendocrine homeostatic control system by studying the 
accommodative regulation mediated by the stress hormones OT, AVP, and 
ACTH. 
(5) We endeavoured to create an in vitro model for exploring stress 
hormone release inducible by the effects of combined exposure, which 
would be suitable also for the standardized monitoring of releasing 
processes.  
(6) In view of the legal regulations pertaining to the limit on ClB exposure, 
we considered ascertaining whether extremely low-dose combined ClB load 
induces changes in the neuroendocrine control of stress hormones an 
important assignment.  
(7) The hormones involved in neuroendocrine regulation, as well as by the 
biogenic amines implementing intercellular communication are essential 
determinants of behavioural patterns. We have investigated the modifying 
effect of ClB exposure on OT and VP release mediated by biogenic amines 
(5-HT, NA). 
(8) We intended to ascertain, whether the stress responses mediated by 
hormones and biogenic amines alter the rapid adaptation pattern – that is, 
animal behaviour. 
(9) Our objectives also included answering the question whether any 
combined chlorobenzene treatment of much smaller dosage than the 
exposure dosage permitted in the relevant legal regulations causes 
measurable changes in the behaviour of test animals. 
(10) The analysis of our findings focused on identifying the homeostatic 
mechanisms potentially related to the changes detected in behavioural 
patterns and/or neuroendocrine regulation by the research protocols outlined 
above. 
(11) Furthermore, we wanted to appraise any additional health risk 
potentially represented by EDCs, in view of the findings obtained with ClB 
as their model substance. 
(12) Finally, by analyzing our results, we wanted to decide whether the 
amended regulations should apply to all EDC compounds characterized by 
or devoid of accumulation. 
Methods 
For the experiments, we have used male (180–350 g weight, 6–8 weeks of 
age at the beginning of the experiments) Wistar (Charles River, Isaszeg, 
Hungary) rats. The animals were kept under controlled circumstances 
(temperature, relative humidity, light/dark periods) in cages of 32×40×18 
cm (maximum 4 individuals in each cage). The test animals were distributed 
to the treatment groups described in Section 3.3. The smaller male (200–
250 g weight, 4–6 weeks of age at the beginning of the experiments) Wistar 
rats were kept separately, but under identical conditions, and ten used as 
intruders during the aggression tests. To the animals, food (CRLT/N, 
Charles River, Hungary) and drinking water were supplied ad libitum. The 
treatments were started after the two-week habituation of the animals to the 
given circumstances and the persons participating in the experiments. The 
researches conducted with the test animals were carried out with the 
permission of the Workplace Committee on Animal Research, University of 
Szeged, with proper respect to the legal regulations pertaining to laboratory 
test animals and experimental procedures. 
Exposures and experimental groups 
The animals were treated with the 1:1 mixture of hexachlorobenzene and 
1,2,4-trichlorobenzene 1:1 (ClB).  The dosing regimen (exposure stress) 
required to maintain a safe protocol had been determined beforehand in 
preliminary experiments. The ingestion route and administration through a 
gastric tube had proven the best for the purposes of the exposure protocol. 
Thus, the animals received ClB in 1-µg/kg (D2, D2-ClB groups) or 0.1-
µg/kg doses (D1, D1-ClB groups) as 1-ml final volume, for 0, 30, 60, or 90 
days. We had tested also alternative routes for implementing the exposure, 
but chose alimentary administration by a gastric tube eventually, as this 
made standardizing the experiment possible. The following groups were 
established upon standardizing the treatment protocol: 
1. ClB-treated groups: Ten animals per group and series underwent 
combined chlorobenzene exposure for 30 days (n=5-5, D1- or D2-ClB-30 
groups), 60 days (n=5-5, D1- or D2-ClB-60 groups), or 90 days (n=5-5, D1- 
or D2-ClB-90 groups) in five series of experiments. Dosing was 
implemented by the oral route of exposure (which is most prevalent in the 
literature), according to an alimentary regimen and using a gastric tube.  
2. Stressed control groups (‘SC’): These animals were treated/stressed over 
0 day, 30 days (n=10, SC-30 group), 60 days (n=10, SC-60 group), or 90 
days (n=10, SC-90 group) by inserting an empty gastric tube. 
3. Absolute control group (‘control’): Untreated/unstressed animals 
(n=10). 
4. Positive control group (‘+C’): The animals (n=10) received the solvent 
of ClB (0.001% ethanol solution) as 1-ml boluses through a gastric tube, 
over 0, 30, 60, or 90 days. 
5. Negative control group (‘–C’): These animals (n=10) received 1-ml 
boluses of drinking water of known solute content through a gastric tube, 
over 0, 30, 60, or 90 days. 
Experimental protocol: The animals underwent treatment for 0, 30, 60, or 
90 days according to the group scheme set out in Section 3.3. Following 
treatments with ClB, we evaluated anxiety with the open field (OF) and the 
elevated plus maze (EPM) tests, and used the modified resident-intruder 
(RI) test to appraise aggressive behaviour among male animals. Upon 
concluding the behaviour tests, blood samples (anticoagulated and native) 
were taken from the animals following decapitation. From these samples, 
stress hormones (ACTH, OT, VP) were determined with the RIA 
(radioimmunoassay) or CLIA method. Serum levels of hepatic transferases 
(indicators of liver function) such as glutamate oxalacetate transaminase 
(GOT), glutamate pyruvate transaminase (GPT), and gamma glutamyl 
transpeptidase (GT) were determined as verified markers of the toxicity of 
ClB exposure. The body weights of the animals, as well as the weights of 
major organs (liver, spleen, kidney, adrenal glands, etc.) were measured 
during and/or after treatment. The changes of weights and data from liver 
enzyme determinations were used to demonstrate the subtoxic effect of the 
ClB doses (D1, D2) administered. 
We prepared primary neurohypophyseal (NH) and adenohypophyseal 
(AdH) cell cultures from the pituitary glands of treated animals. These 
monolayer cultures were used to study the real-time kinetics of ACTH, VP, 
and OT release. The presence of 5-HT and NA receptors, as well as of 
serotonin- and/or norepinephrine-mediated VP and OT secretion were 
studied with RIA in NH cultures. 
Behavioural tests: During the experiment, each animal was used only once 
in the specific behavioural tests. The tests were commenced under identical 
circumstances, after 1 hour of habituation to the room. The animals were 
involved in the examinations in the groups described in the protocol, but in 
a random order. The elements of the behaviour shown were recorded with 
the use of the ceiling-mounted video camera over the test apparatus and the 
connected behavioural software: Ethovision (v2.3, Noldus Information 
Technology, Wageningen, Netherlands). 
Open Field (OF) test: The OF test is a standardized method for the 
appraisal of the locomotor activity, exploratory behaviour, curiosity, 
anxiety, and habituation characteristic of rodents. 
Elevated plus maze (EPM) test: EPM is a standard method for evaluating 
anxiety in rodents. During the tests, the following factors were monitored 
by the computer and/or the persons conducting the study/follow-up control: 
– total duration spent in open and closed arms – preferred area (percentage 
rate of times spent in the open area and in the apparatus) – number of 
entries to the zones – frequency and duration of prancing, cleaning, sniffing, 
freezing. The behaviour of the animals was examined for 3 minutes. 
Testing of aggression among males with the resident-intruder (RI) test: In 
our experimental protocol modified RI tests were performed to study the 
aggression of animals. The resident animal was placed inside an arena 
covered with wood chips and left to habituate for 5 minutes. 
Locomotor/explorative behavioural elements as well as those suggestive of 
the anxiety of the resident were recorded during the test. After habituation, 
the intruder animal was placed into the same arena in the 6
th
 minute of the 
experiment. We observed the behaviour of the animals for 6 minutes. 
Neurohypophyseal (NH) monolayer cell cultures: We removed the pituitary 
glands of the animals subjected to the predefined treatments under sterile 
conditions, and isolated the neurohypophysis using a dissecting microscope. 
Following the removal of membranes, pituicytes were separated 
enzymatically (digestion with trypsin 0.2% for 30 minutes, collagenase 50 
µg/mL for 60 minutes, dispase 50 µg/mL for 60 minutes, DNase 30 µg/mL 
for 60 minutes) and then, mechanically (nylon-blutex filter with 80 µm pore 
size). The cell suspension was placed into a DMEM + 20% FCS + 30U/ml 
Pen-Strep culture medium, and then the viability of the cells was 
determined with the use of the Trypan blue test (≥ 95 %). Thereafter, the 
concentration of the cell suspension was set to 2×105 cell/ml. The final 
concentration of the cell suspension was adjusted to 2×105 cells/mL. The 
suspended cells were transferred to plastic growth chambers coated with 5% 
collagen. Adherent cell cultures were flushed with fresh culture medium 
every 3 days until growth to a confluent state. Then, NH cultures were 
standardized by determining the relative incidence of OT and VP 
production, as well as by inducing specific and non-specific hormone 
release. Samples with a standard deviation not exceeding 5 to 7% were used 
to create the groups defined in the study protocol.  
Adenohypophyseal (AdH) monolayer cell cultures: We removed the 
pituitary glands and isolated the AdH as described for NH cell cultures. 
Following the removal of the membranes, AdH cells were dispersed 
enzymatically (trypsin 0.2% for 30 minutes, collagenase 50 µg/mL for 40 
min, dispase 50 µg/mL for 40 minutes, DNase 30 µg/mL for 20 minutes) 
and mechanically (nylon-blutex filter with 83 µm pore size). The cell 
suspension was placed in a culture medium containing DMEM, 10% FCS, 
and 10 U/mL Pen-Strep. Having checked the viability of cells with the 
trypan blue test (95%), the concentration of the cell suspension was 
adjusted to 2×105 cells/mL. The suspended cells were transferred to plastic 
growth chambers coated with 5% collagen. Adherent cell cultures were 
flushed with fresh culture medium every 3 to 5 days until growth to a 
confluent state. Then, cultures were standardized by determining the 
relative incidence of ACTH release, as well as by specific and non-specific 
stimulation (with arginine-vasopressin and 30 mM potassium, respectively). 
Samples exhibiting ACTH secretion with a standard deviation not 
exceeding 5 to 7% were used to create the study groups.  
In vitro release studies: We replaced the supernatants of monolayer AdH 
and NH cell cultures with physiological culture medium (DMEM without 
FCS), and incubated the cultures at 37 °C in an atmosphere containing 5% 
carbon dioxide. In conformity with the in vitro study protocol, samples were 
obtained at 0.5, 10, 20, 30, 60, and 120 minutes into special plastic tubes, 
which were frozen immediately at -70 °C. These samples were used to 
determine ACTH from AdH cultures, as well as OT and VP hormones from 
NH cultures using RIA or CLIA methods. After registering the kinetics of 
the basic hormone secretion, the cultures were washed again, and then kept 
for 12 hours under physiological circumstances. Then, the kinetics of non-
specific hormone release were determined by adding 30 mM potassium. 
After a 12-hour period of rest, ACTH release was induced with arginine 
vasopressin, along with the secretion of VP and OT, respectively, with 
dopamine and histamine as specific agents. The kinetics of hormone 
secretion were also measured. 
NH monoamine receptor studies: Under the established and standardized 
environmental conditions, cultures were washed first and then, incubated 
for 120 minutes. Following incubation, samples were obtained from the 
supernatants and stored at -70 °C, until the determination of VP and OT 
levels by RIA. Confluent cultures prepared from the animals (controls and 
ClB-treated) were incubated in vitro for 60 minutes in 10
-6
 M 5-HT or NA. 
At the end of the treatment period, the conditioned media of cell cultures 
were collected, frozen  at -70 °C, and the concentrations of VP and OT 
released into the media were determined by RIA. 
Determination of AVP, OT and ACTH from the supernatant medium: We 
determined VP and OT levels in the supernatant media of NH cell cultures 
using protocols as described in the literature. Prior to sampling, media had 
been conditioned in compliance with protocols for the cell cultures. The 
supernatant was removed from the cultures and stored at -70 °C until 
measurement. VP and OT were determined in the samples with a modified 
RIA method. As shown by the standard curves, the measurement range of 
the assay was 1 to 128 pg VP/OT, whereas its lower limit of sensitivity was 
1 pg/assay tube. The protein content of the samples was determined with the 
modified method of Lowry. Our results are expressed per milligrams of 
protein content. ACTH was determined with RIA and CLIA methods, using 
the equipment (Immulite 2000, Siemens Healthcare Diagnostic, Deerfield, 
IL, USA, and DPC kit) of the Clinical Endocrinology Unit of the 1
st
 
Department of Internal Medicine of the University of Szeged, Faculty of 
Medicine. 
The determination of AVP, OT, and ACTH in serum: We collected the blood 
samples of decapitated animals into polystyrene tubes containing EDTA. 
Following centrifugation for 10 minutes at 8000 rpm at 4 °C, the plasma 
was removed and stored at -70 °C until measurement. The serum levels of 
VP, OT, and ACTH were measured with the RIA and LIA methods as 
described earlier. 
Statistical analysis: We analyzed the data with v13.0 of the SPSS for 
Windows statistical software (SPSS Incorporated, Chicago, IL, USA). After 
the examination of the distributions, the data originating from the 
behavioural tests were analyzed with the use of the ANOVA method. 
 
Summary of results: 
(1) Starting on Day 60, the serum level of AVP increased progressively 
with both (D1 and D2) doses, and the difference vs. control reached 
statistical significance after 90 days of exposure. 
(2) Compared to controls, the increase of serum OT level was statistically 
significant as early as after 60 days of exposure.  
(3) Serum ACTH level increased after both doses. However, while the 
increase induced by the larger dose became significant after 30 days of 
exposure, the smaller dose achieved the same only after 90 days of 
exposure. 
(4) In neurophyseal in cell cultures, the in vitro secretion of VP and OT 
increased in a time-dependent fashion after both (D1 and D2) D1 doses of 
ClB.  
(5) Both 5-HT and NA significantly increased the release of VP and OT 
by neurohypophyseal cell cultures. Specifically, we found enhanced 
monoamine-mediated VP and OT release following the treatment of 
standardized cell cultures prepared from NH monolayer controls and ClB 
pre-treated systems with 10-6 M 5-HT or NA. 
(6) (6) Our findings are in partial agreement with observations published 
in the literature, which include elevated serum VP level found in psychiatric 
disorders associated with anxiety or aggression. In our experiments, the 
quantity of active OT and VP increased depending on the extent of ClB 
accumulation – both in vitro and in vivo. This suggests that the actual ratio 
of OT and VP hormones might play a decisive role in behavioural changes. 
Chronic exposure to ClB administered at two dose levels (D1 and D2) for 
30, 60, and 90 days altered the behaviour of the animals – that is, increased 
both anxiety (as shown by OF and EPM tests) and aggression (as 
demonstrated by ERI tests) [1-2]. 
 
Based on the findings, we grouped our results and conclusions around the 
topics defined in the objectives of this research. 
Owing to their chemical nature, physical-chemical properties, known 
biological actions (EDC effects), and social implications (chemicalization, 
social activities, xenobiotic character) ClB compounds are ubiquitous 
substances [6-9]. We demonstrated their presence in all levels of evolution 
representing a hierarchy of complexity. Therefore, according to the 
approach of environmental science, they are suitable for use in model 
studies of POP/EDC exposure. We intended to investigate multiple 
chemical exposures by selecting ClB compounds as the exposure agents. 
Although most exposure studies published in the literature evaluate 
responses to a single effect only, this is unrealistic, as all systems on Earth 
(inanimate objects, living organisms, and the society) are subject to multiple 
exposures simultaneously. The research methodology studies required 
before investigating the effects of even the simplest forms of combined 
exposure led to the development of standardized models for evaluating the 
impact of exposure to several factors [5]. Methodology studies have thus 
accomplished the standardization of the experimental system by suitable 
exposure routes. 
Our results with combined, extremely low-dose, long-term, pre-
standardized ClB treatment simulating gastrointestinal exposure contribute 
novel information [3-4]. 
A. In Wistar rats, treatment with ClB administered through a gastric tube 
in extremely low, subtoxic doses (0.1 and 1 µg/kg body weight/day) was 
associated with changes in the serum levels of OT, VP, and ACTH – this 
confirmed the alteration of neuroendocrine regulation. 
B. Additionally, we detected substantial changes in OT and VP release 
mediated by the monoamine (serotonin and norepinephrine) system suitable 
for the investigation of neuroendocrine regulation – such changes have not 
yet been reported from earlier studies. 
C. In addition to performing in vivo studies, we confirmed the elevation 
of the serum level of the active fraction of the stress hormones in question 
(i.e. VP and OT) also by conducting in vitro experiments.  
D. The ClB-induced enhancement of serotonin- and norepinephrine-
mediated VP and OT release correlated with changes in the behavioural 
patterns of the laboratory animals used in the experimental models. 
Specifically, we observed a dose-related and time-dependent increase of 
anxiety and aggression. 
E. The abnormalities detected in the neuroendocrine homeostatic control 
system manifested as behavioural changes. Presenting the results at the 
mechanistic level, we have suggested that the ratio of the active forms of 
OT and VP may have a role in the control of these behaviours. The protocol 
of our study has contributed data appropriate for confirming this suggestion. 
F. The properties of EDCs present in the environment are comparable to 
those of ClBs. As shown by our results, these may be regarded as 
significant chemical and biological risk factors. 
– These substances represent a chemical risk owing to their xenobiotic 
nature, represented by persistence, reactive and lipophilic properties, 
etc. 
– They represent a biological risk in addition, owing to their chemical 
properties, as well as because of their dose-dependent effect, and 
influence on homeostatic regulatory systems. Aggregately, these result 
in the changes of behavioural and rapid adaptation patterns. 
Eventually, this might even increase the risk of psychiatric disease as 
far as human effects are concerned. 
According to our findings obtained in an experimental model, the actions of 
POPs and EDCs – ubiquitous in the environment as components of the 
chemical load – as exposure agents generate changes in the homeostasis of 
biological systems even in extremely low doses, when acting on the long 
term. In biological systems, these lead to alterations in the potential for 
homeostatic adaptation, which in turn induce changes in rapid adaptation 
patterns and behaviour (involving cognitive processes and social behaviour etc.). 
In view of our results, reviewing current legal regulations on the use of the 
POPs/EDCs studied seems justified. 
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